CSPC Pharmaceutical Group
This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these messages)
|
CSPC Pharmaceutical Group (simplified Chinese: 石药集团有限公司; traditional Chinese: 石藥集團有限公司; pinyin: Shíyào jítuán yǒuxiàn gōngsī) (China Pharma, SEHK: 1093, Hang Seng Index component) researches, develops, manufactures and sells pharmaceutical products. Its headquarters is in China's Hebei Province.
CSPC produces both active pharmaceutical ingredient (API) and formulations. API products include penicillin, cefalosporins, synthetic vitamins, caffeine and ranitidine. Formulations include antibiotics, butylphthalide (NBP) and analgesics, in addition to nearly 1,000 other products.
CSPC's 15,000 employees are divided among more than ten subsidiaries, including CSPC Zhongrun, Weisheng, Zhongnuo and NBP.
CSPC Pharma's total assets are valued above RMB 8 billion. In 2007, CSPC Pharma achieved sales of RMB 8 billion and net income of RMB 485 million. Direct exports of US$300 million ranked CSPC first among China's pharmaceutical enterprises.[1]
One subsidiary, China Pharmaceutical Group Co., Ltd (China Pharma) is based in Hong Kong. It is listed on the Hang Seng China-Affiliated Corporations Index. In 2003 and 2004, China Pharma was listed as one of 100 excellent listed companies with turnover less than $1 billion.
CSPC Pharma is recognized as one of China's “500 Most Valuable Chinese Brands” and “Top 500 Chinese Enterprises.” In 2007, CSPC Pharma ranked second among China's top 100 pharmaceutical industry companies.[2]
See also
[edit]References
[edit]External links
[edit]- Official website
- Business data for CSPC Pharmaceutical Group:
- CSPC Zhongrun official website at the Wayback Machine (archived January 5, 2009)
and
Industry
- CK Hutchison Holdings
- Galaxy Entertainment Group
- MTR Corporation
- Geely Auto
- Alibaba Health
- CITIC Limited
- WH Group
- China Resources Beer
- Orient Overseas (International) Limited
- Tingyi
- Sinopec
- Techtronic Industries
- Tencent
- China Unicom
- PetroChina
- Xinyi Glass
- Zhongsheng Group
- CNOOC Limited
- China Mobile
- Xinyi Solar
- Semiconductor Manufacturing International Corporation
- Lenovo
- Hengan International
- China Shenhua Energy
- CSPC Pharmaceutical Group
- Sinopharm Group
- Sino Biopharmaceutical Limited
- BYD Company
- China Hongqiao Group
- Xiaomi
- Budweiser Brewing Company APAC
- Sands China
- Chow Tai Fook
- Li Auto
- Anta Sports
- WuXi Biologics
- Shenzhou International
- Mengniu Dairy
- Li-Ning
- WuXi AppTec
- Sunny Optical
- Zijin Mining
- Meituan
- Hansoh Pharmaceutical
- JD Health
- Haier
- Haidilao
- JD.com
- Nongfu Spring
- Baidu
- Trip.com Group
- Alibaba Group
- NetEase
- CanSino Biologics
- CSPC Zhongrun
- China Nepstar
- Fosun Pharmaceutical
- Guangzhou Pharmaceuticals
- Guangyuyuan
- Guizhentang Pharmaceutical Company
- Harbin Pharmaceutical Group
- Hebei Yuxing Bio-Engineering Co. Ltd
- Huadong Medicine
- Jilin Aodong Medicine
- Lijun International Pharmaceutical (Holding) Co. Ltd.
- Kunming Pharmaceutical Corporation
- Nanjing Ange Pharmaceutical
- North China Pharmaceutical Group
- Salubris Pharmaceuticals
- Shanghai Pharmaceuticals Holding Co., Ltd.
- Shenzhen Kangtai Biological Products
- Shijiazhuang Pharma Group
- Sihuan Pharmaceutical
- Simcere Pharmaceutical
- China National Pharmaceutical Group
- Sinovac Biotech
- Tasly
- Tong Ren Tang
- Xiangxue Pharmaceutical
- Yangtze River Pharmaceutical Group
- Yunnan Baiyao Group
- WuXi AppTec